Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
about
Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: multiscale theoretical simulationsEffects of hydroxylated carbon nanotubes on the aggregation of Aβ16-22 peptides: a combined simulation and experimental study.Effect of intra-membrane C60 fullerenes on the modulus of elasticity and the mechanical resistance of gel and fluid lipid bilayers.The interplay between carbon nanomaterials and amyloid fibrils in bio-nanotechnology.Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.Molecular dynamics simulation studies of the structural response of an isolated Aβ1-42 monomer localized in the vicinity of the hydrophilic TiO 2 surface.The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.Binding of fullerenes to amyloid beta fibrils: size matters.Unraveling origins of the heterogeneous curvature dependence of polypeptide interactions with carbon nanostructures.Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4′ benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulationsInhibitory effect of hydrophobic fullerenes on the β-sheet-rich oligomers of a hydrophilic GNNQQNY peptide revealed by atomistic simulations
P2860
Q28392405-B9B1F8CE-4A92-4F05-9BCB-2B4523AF2258Q34423854-F4DA831F-576F-452C-82C5-5E9B2D8CF900Q35792888-7EBB5775-086E-4E1B-9161-248D6BA2193FQ38112627-38D45616-C844-49CB-B13A-0835432DED29Q38558352-479FE5B1-3DC7-4419-99E6-F173005E9040Q45207430-4996B666-1AB4-486E-8BEA-9584AB7309DFQ46367449-0119A39F-2822-4311-A196-F02243D7BF3FQ46561654-0A463C8F-B84E-48BB-9252-F4635298FFCCQ47442457-CAB81A3A-F8E2-4C0F-8510-07D7C1A45C9FQ53405972-9A8F0356-98CC-45CB-BDEF-C9A22998DBEFQ57781259-E5AAEEA7-E26A-4A4B-9619-7EEAFD766CADQ57840236-6101BCDB-B639-40CB-9E4D-F55D738748E6
P2860
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
type
label
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
prefLabel
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
P2093
P2860
P356
P1476
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
P2093
Francesca Lugli
Ricardo D Enriz
Sebastián A Andujar
Siegfried Höfinger
P2860
P304
P356
10.1039/C2CP40680B
P407
P577
2012-05-17T00:00:00Z